Generation of a human induced pluripotent stem cell line from a CHARGE syndrome patient with CHD7 mutation...

Area of Science:

• Genetics
• Developmental Biology
• Stem Cell Research

Background:

• CHARGE syndrome is a complex neurodevelopmental disorder affecting multiple organ systems.
• The CHD7 gene is identified as the primary genetic cause of CHARGE syndrome.
• Existing research necessitates patient-specific cellular models for in-depth study.

Purpose of the Study:

• To establish a human induced pluripotent stem cell (iPSC) line from a patient diagnosed with CHARGE syndrome.
• To characterize the generated iPSC line for pluripotency and differentiation capabilities.
• To provide a valuable tool for investigating CHARGE syndrome pathogenesis and facilitating drug screening.

Main Methods:

• Generation of iPSC line from peripheral blood mononuclear cells of a CHARGE syndrome patient.
• Culturing and maintenance of iPSC line under standard conditions.
• Assessment of iPSC line characteristics including morphology, pluripotency markers, karyotype, and differentiation potential into three germ layers.

Main Results:

• A novel human iPSC line was successfully generated, carrying a de novo heterozygous CHD7 mutation (c.3982C>T).
• The iPSC line demonstrated typical human embryonic stem cell morphology and expressed key pluripotency markers.
• The iPSC line possessed a normal karyotype and exhibited the capacity for differentiation into ectoderm, mesoderm, and endoderm lineages.

Conclusions:

• The established CHARGE syndrome iPSC line serves as a robust cellular model for the disorder.
• This iPSC line is instrumental for advancing the understanding of CHARGE syndrome's underlying mechanisms.
• The patient-derived iPSC line offers a platform for preclinical drug screening and therapeutic development for CHARGE syndrome.